Piscataqua Savings Bank cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 15.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,677 shares of the healthcare conglomerate's stock after selling 1,056 shares during the quarter. UnitedHealth Group comprises approximately 2.6% of Piscataqua Savings Bank's portfolio, making the stock its 8th biggest position. Piscataqua Savings Bank's holdings in UnitedHealth Group were worth $2,973,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also recently modified their holdings of the company. Capital & Planning LLC grew its stake in shares of UnitedHealth Group by 19.2% during the 4th quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate's stock valued at $248,000 after purchasing an additional 79 shares during the period. Brighton Jones LLC grew its position in shares of UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after acquiring an additional 28,231 shares during the period. Union Bancaire Privee UBP SA bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $27,233,000. Revolve Wealth Partners LLC grew its holdings in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after purchasing an additional 2,324 shares during the period. Finally, Silver Oak Securities Incorporated grew its holdings in UnitedHealth Group by 24.0% during the fourth quarter. Silver Oak Securities Incorporated now owns 2,878 shares of the healthcare conglomerate's stock valued at $1,462,000 after purchasing an additional 557 shares during the period. 87.86% of the stock is currently owned by institutional investors.
UnitedHealth Group Trading Up 2.5%
Shares of NYSE UNH opened at $303.24 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The business has a fifty day simple moving average of $409.03 and a two-hundred day simple moving average of $484.21. The firm has a market cap of $275.08 billion, a PE ratio of 19.56, a price-to-earnings-growth ratio of 1.37 and a beta of 0.44. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the prior year, the firm posted $6.91 EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be issued a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.92%. The ex-dividend date is Monday, June 16th. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio (DPR) is currently 37.02%.
Analysts Set New Price Targets
Several research firms recently issued reports on UNH. Argus lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. Oppenheimer dropped their target price on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a report on Wednesday, May 14th. KeyCorp dropped their target price on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating for the company in a report on Monday, June 2nd. Erste Group Bank lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 30th. Finally, Wells Fargo & Company restated an "overweight" rating on shares of UnitedHealth Group in a research report on Friday. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have assigned a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $428.43.
View Our Latest Report on UnitedHealth Group
Insider Buying and Selling
In related news, Director Timothy Patrick Flynn bought 1,533 shares of the business's stock in a transaction on Wednesday, May 14th. The stock was acquired at an average cost of $320.80 per share, with a total value of $491,786.40. Following the purchase, the director now directly owns 6,033 shares of the company's stock, valued at $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Stephen J. Hemsley bought 86,700 shares of the business's stock in a transaction on Friday, May 16th. The shares were acquired at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the purchase, the chief executive officer now owns 679,493 shares of the company's stock, valued at $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased 109,408 shares of company stock worth $31,607,768 in the last three months. Corporate insiders own 0.33% of the company's stock.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report